Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00869375 · ClinicalTrials.gov registry record · NA

Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia

A NA study, sponsored by University of Oklahoma.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT00869375: Clinical Trial NA study, sponsored by University of Oklahoma.

NCT00869375 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00869375, a NA study, was terminated before completion, sponsored by University of Oklahoma.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effects (positive and negative) of two different devices available to treat people with critical limb ischemia, which involves a sudden decrease in blood flow to the leg that causes a potential threat to the limb and causes pain at rest, ulcers or gangrene. One device is the Clearway balloon, which delivers a drug to dissolve the clot where the blockage is. The other device is the Angiojet, which removes the clot in a mechanical way ("vacuum" effect). This research is being done because currently there is no single proven effective treatment for this condition. Even though, both these devices are commonly used in the clinical practice to treat critical limb ischemia, there are no studies that compare these devices and help us see which one may be better for these patients.

Interventions

  • DEVICE Endovascular peripheral intervention

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2009-04
Est. Completion 2012-06
Phase NA
University of Oklahoma

358 total trials

Why NCT00869375 stopped before completion

NCT00869375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Endovascular peripheral intervention is the first listed.

NCT00869375 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00869375 about?

NCT00869375 is a clinical study titled "Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia". The purpose of this study is to compare the effects (positive and negative) of two different devices available to treat people with critical limb ischemia, which involves a sudden decrease in blood flow to the leg that causes a potential threat to the limb and causes pain at rest, ulcers or gangrene...

What is the current status of trial NCT00869375?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2009-04. Estimated completion is 2012-06.

What interventions are being tested in trial NCT00869375?

The interventions under investigation include: Endovascular peripheral intervention (DEVICE).

Who is sponsoring clinical trial NCT00869375?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00869375's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00869375, the US trial registry maintained by the National Library of Medicine. NCT00869375 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.